Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications

Published:2024-03-14 Issue:6 Volume:80 Page:827-838
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Wang Zhipeng,Wang Hongsen,Bu Chen,Meng Bosu,Mu Yuhui,Gao Shouhong,Chen Wansheng,Tao Xia

Funder

the National Natural Science Foundation of China

the Shanghai Municipal Health Commission

Jin-Zi-Ta Talent projects of Shanghai Changzheng Hospital, China

Clinical Medical Technology Incubation Project of Shanghai Changzheng Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00228-024-03626-4.pdf

Reference106 articles.

1. Helmy KY, Patel SA, Nahas GR et al (2013) Cancer immunotherapy: accomplishments to date and future promise. Ther Deliv 4(10):1307–1320

2. Gabora K, Piciu A, Bădulescu IC et al (2019) Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors. Drug Metab Rev 51(4):562–569

3. Bilen MA, Patel A, Hess KR et al (2016) Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. Cancer Chemother Pharmacol 78(1):167–171

4. Shu M, Zai X, Zhang B et al (2016) Hypothyroidism side effect in patients treated with sunitinib or sorafenib: clinical and structural analyses. PLoS ONE 11(1):e147048

5. Thomson RJ, Moshirfar M, Ronquillo Y (2023) Tyrosine Kinase Inhibitors. In StatPearls. StatPearls Publishing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP